Selig, D.; Aminu, F.; Cammarata, S.; Chen, T.; Dolak, L.; Duprez, S.; Ecker, S.; Gault, L.; George, S.; Harkins, M.;
et al. Landscape of Post-Marketing Requirements Under the Pediatric Research Equity Act for Antibiotics from 2009–2024. Antibiotics 2025, 14, 583.
https://doi.org/10.3390/antibiotics14060583
AMA Style
Selig D, Aminu F, Cammarata S, Chen T, Dolak L, Duprez S, Ecker S, Gault L, George S, Harkins M,
et al. Landscape of Post-Marketing Requirements Under the Pediatric Research Equity Act for Antibiotics from 2009–2024. Antibiotics. 2025; 14(6):583.
https://doi.org/10.3390/antibiotics14060583
Chicago/Turabian Style
Selig, Daniel, Funmi Aminu, Sue Cammarata, Ting Chen, Lauren Dolak, Stephen Duprez, Stephanie Ecker, Lisa Gault, Sandra George, Margaret Harkins,
and et al. 2025. "Landscape of Post-Marketing Requirements Under the Pediatric Research Equity Act for Antibiotics from 2009–2024" Antibiotics 14, no. 6: 583.
https://doi.org/10.3390/antibiotics14060583
APA Style
Selig, D., Aminu, F., Cammarata, S., Chen, T., Dolak, L., Duprez, S., Ecker, S., Gault, L., George, S., Harkins, M., Litchmore, C., Serenko, M., Waverczak, W., & Girgenti, D.
(2025). Landscape of Post-Marketing Requirements Under the Pediatric Research Equity Act for Antibiotics from 2009–2024. Antibiotics, 14(6), 583.
https://doi.org/10.3390/antibiotics14060583
